» Articles » PMID: 25714311

Transition Zone Prostate Cancer: Revisiting the Role of Multiparametric MRI at 3 T

Overview
Specialties Oncology
Radiology
Date 2015 Feb 26
PMID 25714311
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

OBJECTIVE. The purpose of this study was to retrospectively evaluate the impact of multiparametric prostate MRI, including diffusion-weighted imaging (DWI) performed using different b values as well as dynamic contrast-enhanced MRI (DCE-MRI) on the accuracy, sensitivity, and specificity for transition zone (TZ) tumor detection and localization. MATERIALS AND METHODS. We included 106 prostate cancer patients (mean age [± SD], 62 ± 7 years) who underwent 3-T MRI with a pelvic phased-array coil before radical prostatectomy. Three radiologists independently reviewed cases to record the likelihood of tumor in each of six TZ regions. Scores were initially assigned using T2-weighted imaging alone, reassigned after integration of DWI at b = 1000 s/mm(2) and corresponding apparent diffusion coefficient (ADC) maps, reassigned again after integration of DWI at b = 2000 s/mm(2), and reassigned a final time after integration of DCE-MRI. Generalized estimating equations based on binary logistic regression were used to compare sessions for TZ tumor detection, using prostatectomy findings as reference standard. RESULTS. Of the TZ sextants, 9.7% (62/636) contained tumor. All readers had higher sensitivity for T2-weighted imaging integrated with DWI at b = 1000 s/mm(2) and ADC compared with T2-weighted imaging alone (reader 1, 54.8% vs 33.9%; reader 2, 53.2% vs 22.6%; and reader 3, 50.0% vs 19.4% [p ≤ 0.002]); two readers had further increased sensitivity also incorporating b = 2000 s/mm(2) (reader 1, 74.2% and reader 2, 62.9%; p ≤ 0.011), and one reader had further increased sensitivity also incorporating both b = 2000 s/mm(2) and DCE-MRI (reader 3, 61.3%, p = 0.013). DCE-MRI otherwise did not improve sensitivity (p ≥ 0.054). Other measures were similar across the four sessions (reader 1, specificity 97.4-98.3% and accuracy 91.2-95.9%; reader 2, specificity 95.8-98.4% and accuracy 91.0-92.6%; reader 3, specificity 90.9-96.7% and accuracy 88.1-89.2%). CONCLUSION. DWI assists TZ tumor detection through higher sensitivity, particularly when using a very high b value; DCE-MRI lacks further additional benefit.

Citing Articles

Diffusion weighted image-guided transitional zone scoring in the detection of transitional zone prostate cancer: comparison with current PI-RADS v2.1 scoring.

Lee M, Park J, Kim S, Kim T, Oh S, Moon M Abdom Radiol (NY). 2024; .

PMID: 39354237 DOI: 10.1007/s00261-024-04615-y.


Radiomics from multisite MRI and clinical data to predict clinically significant prostate cancer.

Krauss W, Frey J, Heydorn Lagerlof J, Liden M, Thunberg P Acta Radiol. 2023; 65(3):307-317.

PMID: 38115809 PMC: 10964389. DOI: 10.1177/02841851231216555.


Transitional zone prostate cancer: Performance of texture-based machine learning and image-based deep learning.

Lee M, Kim Y, Moon M, Kim K, Park J, Sung C Medicine (Baltimore). 2023; 102(39):e35039.

PMID: 37773806 PMC: 10545268. DOI: 10.1097/MD.0000000000035039.


A narrative review of biparametric MRI (bpMRI) implementation on screening, detection, and the overall accuracy for prostate cancer.

Greenberg J, Koller C, Casado C, Triche B, Krane L Ther Adv Urol. 2022; 14:17562872221096377.

PMID: 35531364 PMC: 9073105. DOI: 10.1177/17562872221096377.


Combination of MRI prostate and 18F-DCFPyl PSMA PET/CT detects all clinically significant prostate cancers in treatment-naive patients: An international multicentre retrospective study.

Parathithasan N, Perry E, Taubman K, Hegarty J, Talwar A, Wong L J Med Imaging Radiat Oncol. 2022; 66(7):927-935.

PMID: 35170858 PMC: 9790525. DOI: 10.1111/1754-9485.13382.